Loading paragraph...
Today's Biggest Stock Gainers
| Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
|---|---|---|---|---|---|---|---|
| ANGH | Anghami | $3.83 | $1.51 | 65.08% | 40.3M | $16M | $2.25$8.40 |
| ESHA | Esh Acquisition Corp. | $20.91 | $6.53 | 45.41% | 7.1M | $56M | $10.76$27.00 |
| SIDU | Sidus Space | $3.56 | $0.89 | 33.34% | 108.7M | $94M | $0.63$3.75 |
| ULY | Urgent.ly | $3.60 | $0.84 | 30.44% | 13.5M | $6.0M | $1.74$17.99 |
| VNDA | Vanda Pharmaceuticals | $9.00 | $1.97 | 28.02% | 20.9M | $415M | $3.81$9.60 |
| BENF | Beneficient | $7.16 | $1.40 | 24.31% | 175.7K | $81M | $1.75$12.48 |
| AXSM | Axsome Therapeutics | $181.12 | $32.33 | 21.73% | 2.1M | $7.5B | $79.19$182.72 |
| AEI | Alset | $3.25 | $0.51 | 18.61% | 102.9K | $107M | $0.70$4.55 |
| BYFC | Broadway Financial | $7.09 | $1.08 | 17.93% | 84.5K | $55M | $5.51$9.46 |
| PODC | PodcastOne | $2.50 | $0.38 | 17.74% | 109.7K | $57M | $1.28$2.94 |
Related Articles
Featured Article
2 Under-the-Radar Stocks to Buy Heading Into 2026
Prosper Junior Bakiny|Dec 1, 2025
These drugmakers are poised to profit from their innovative engines.
Should You Invest in This Under-the-Radar Weight Loss Stock?
Prosper Junior Bakiny|Nov 30, 2025
This small-cap drugmaker just soared on positive clinical trial data, but should you jump on the bandwagon?
Prediction: These 2 Under-the-Radar Stocks Could Beat the Market in the Next 5 Years
Prosper Junior Bakiny|Sep 30, 2025
Both should have significant catalysts by the end of the decade.
Advertisement
3 Bargain Stocks to Buy in a Market That's Priced for Perfection
Yes, bargains can still be found in the stock market.
1 Under-the-Radar Biotech Stock to Buy and Hold
Prosper Junior Bakiny|Sep 29, 2024
It could be an industry giant in the making.
Should You Buy This Sinking Stock on the Dip?
Prosper Junior Bakiny|Jun 27, 2024
The biotech isn't having the best year.
Prediction: These 2 Growth Stocks Could Triple By 2030
Prosper Junior Bakiny|May 11, 2024
These companies have a habit of silencing the bears.
Buying These Dirt-Cheap Stocks Could Be a Brilliant Move
The price could be right for these three biopharma stocks.
These 3 Stocks Have Underperformed the Market This Year. Is Now the Time to Buy?
Sushree Mohanty|Aug 24, 2023
Today's market loser could be tomorrow's market winner.
